Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)

NCT05136703 is registered in ClinicalTrials.gov with Florida International University as lead sponsor.

NCT NCT05136703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05136703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)
Lead sponsor
Florida International University
Phase
Not applicable
Overall status
Recruiting
Start date
August 30, 2022
Completion date
December 31, 2027
Enrollment
150 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

depression, hiv-1-infection, inflammation